letter from CANCER delineating those who warrant to be followed with brain MRIs
I provide this for those to whom it applies to cite
It is only a letter to a leading journal, whereas those oncologists who "follow" will wait until it is published as consensus recommendation
Those factors which caught my eye were that it was younger, ER+, her2+ who only had one met (ie, treatable with cyberknife), whose first met was to the CNS who had the chance for longest survival
Those who are her2+ ER- should also note that they are more at risk of the mets in the first place and once tykerb/lapatinib becomes available their survival may be altered (let's all hope!)
I hope this is not too scary, Rather to be used as ammunition to prevent the
mets from appearing and colonizing undetected due to unwillingness of oncologists to try to detect early when most treatable(will post fascinating article of incredible high tech model of how brain mets occur)
Hope this helps!
|